These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 12658378

  • 1. Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety.
    Zwanzger P, Jarry H, Eser D, Padberg F, Baghai T, Schule C, Ella R, Möller HJ, Rupprecht R.
    J Neural Transm (Vienna); 2003 Mar; 110(3):313-6. PubMed ID: 12658378
    [Abstract] [Full Text] [Related]

  • 2. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 3. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Nov; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 4. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 5. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E, Tõru I, Mäemets K, Sepp S, Vasar V, Shlik J, Zharkovsky A.
    J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
    [Abstract] [Full Text] [Related]

  • 6. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
    Leicht G, Mulert C, Eser D, Sämann PG, Ertl M, Laenger A, Karch S, Pogarell O, Meindl T, Czisch M, Rupprecht R.
    Biol Psychiatry; 2013 Feb 15; 73(4):337-44. PubMed ID: 23059050
    [Abstract] [Full Text] [Related]

  • 7. Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels.
    Radu D, Ahlin A, Svanborg P, Lindefors N.
    Psychopharmacology (Berl); 2002 Jun 15; 161(4):396-403. PubMed ID: 12073167
    [Abstract] [Full Text] [Related]

  • 8. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan 15; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 9. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R.
    J Psychopharmacol; 2011 Jan 15; 25(1):52-9. PubMed ID: 20498136
    [Abstract] [Full Text] [Related]

  • 10. The ventilatory response to cholecystokinin tetrapeptide in healthy volunteers.
    Katzman MA, Duffin J, Shlik J, Bradwejn J.
    Neuropsychopharmacology; 2002 Jun 15; 26(6):824-31. PubMed ID: 12007753
    [Abstract] [Full Text] [Related]

  • 11. Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations.
    Zwanzger P, Eser D, Romeo E, di Michele F, Baghai TC, Pasini A, Padberg F, Rupprecht R.
    Psychoneuroendocrinology; 2009 Nov 15; 34(10):1586-9. PubMed ID: 19501468
    [Abstract] [Full Text] [Related]

  • 12. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C.
    J Psychiatr Res; 2009 Jan 15; 43(4):393-400. PubMed ID: 18534623
    [Abstract] [Full Text] [Related]

  • 13. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks.
    Eser D, Uhr M, Leicht G, Asmus M, Länger A, Schüle C, Baghai TC, Mulert C, Rupprecht R.
    J Psychiatr Res; 2011 Jan 15; 45(1):60-3. PubMed ID: 20542521
    [Abstract] [Full Text] [Related]

  • 14. Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J, Koszycki D, Couëtoux du Tertre A, Paradis M, Bourin M.
    Psychopharmacology (Berl); 1994 Mar 15; 114(2):257-61. PubMed ID: 7838917
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J, Koszycki D.
    Scand J Clin Lab Invest Suppl; 2001 Mar 15; 234():19-27. PubMed ID: 11713976
    [Abstract] [Full Text] [Related]

  • 16. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP.
    Neuroimage; 2006 Jul 01; 31(3):1197-208. PubMed ID: 16600640
    [Abstract] [Full Text] [Related]

  • 17. Dose ranging study of the effects of cholecystokinin in healthy volunteers.
    Bradwejn J, Koszycki D, Bourin M.
    J Psychiatry Neurosci; 1991 Jul 01; 16(2):91-5. PubMed ID: 1911739
    [Abstract] [Full Text] [Related]

  • 18. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
    Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J.
    Psychiatry Res; 2010 Jul 30; 178(2):342-7. PubMed ID: 20471107
    [Abstract] [Full Text] [Related]

  • 19. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
    Plag J, Gaudlitz K, Zschucke E, Yassouridis A, Pyrkosch L, Wittmann A, Holsboer F, Ströhle A.
    Curr Pharm Des; 2012 Jul 30; 18(35):5619-26. PubMed ID: 22632477
    [Abstract] [Full Text] [Related]

  • 20. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Jul 30; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.